MYC and mature T-cell and NK-cell non-Hodgkin lymphoma: The expression of c-myc was dose-dependently decreased by the treatment with AT56 in PTCL cells (Fig. 3d), indicating the inhibitory effects of AT56 in cell growth in vitro.